A Study of MORAb-202 Versus Investigator's Choice Chemotherapy in Female Participants With Platinum-resistant High-grade Serous (HGS) Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Clinical trial NCT05613088 · COMPLETED
Trial details
- NCT number
- NCT05613088
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-01
- Primary completion
- 2024-06-17
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.